TLX2 and ischemia: To confirm that the inhibition of the NCX isomer is indeed responsible for the moderation of ischemia-induced transmitter release, selective antagonists, with and without effects on NMDA and Na+ channels, are needed that are capable of inhibiting NCX acting in reverse mode.